{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:47:43Z","timestamp":1791665263974,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ando.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:26:33Z","timestamp":1464135993000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Prolactinoma and pregnancy: From the wish of conception to lactation"],"prefix":"10.1016","volume":"77","author":[{"given":"Dominique","family":"Maiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2016.04.001_bib0005","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0010","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992\u20132007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.04.001_bib0020","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMcp025334","article-title":"Clinical practice. Prolactinoma","volume":"349","author":"Schlechte","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2016.04.001_bib0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ando.2012.03.024","article-title":"2012 update in the treatment of prolactinomas","volume":"73","author":"Maiter","year":"2012","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2016.04.001_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0035","first-page":"1","article-title":"Treatment of hyperprolactinemia: a systematic review and meta-analysis","volume":"24","author":"Wang","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.ando.2016.04.001_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1022375429083","article-title":"Medical management of prolactin-secreting pituitary adenomas","volume":"5","author":"Molitch","year":"2002","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2016.04.001_bib0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.beem.2011.05.011","article-title":"Prolactinoma in pregnancy","volume":"25","author":"Molitch","year":"2011","journal-title":"Best Practice Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0050","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","article-title":"Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas","volume":"95","author":"Ono","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0055","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.04.001_bib0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2016.04.001_bib0065","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2016.04.001_bib0070","series-title":"97th Annual Meeting of the Endocrine Society","article-title":"Prolactinomas in pediatric age: characteristics and long-term outcome","author":"Brunelle","year":"2015"},{"key":"10.1016\/j.ando.2016.04.001_bib0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3171\/jns.1983.58.5.0685","article-title":"Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors","volume":"58","author":"Laws","year":"1983","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2016.04.001_bib0080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-1000","article-title":"Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients","volume":"166","author":"Primeau","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.04.001_bib0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-0528.1978.tb14949.x","article-title":"Induction of ovulation with clomiphene and human chorionic gonadotrophin in women with hyperprolactinaemic amenorrhoea","volume":"85","author":"McGarrigle","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ando.2016.04.001_bib0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0890-6238(02)00055-2","article-title":"Pregnancy outcome after cabergoline treatment in early weeks of gestation","volume":"16","author":"Ricci","year":"2002","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ando.2016.04.001_bib0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2265.2007.03000.x","article-title":"Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study","volume":"68","author":"Colao","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2016.04.001_bib0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","article-title":"Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103\u00a0pregnancies and a review of the literature","volume":"13","author":"Stalldecker","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2016.04.001_bib0105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12370","article-title":"Outcome of prolactinoma after pregnancy and lactation: a study on 73\u00a0patients","volume":"80","author":"Domingue","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2016.04.001_bib0110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/jc.2012-3039","article-title":"Results of a single-center 10-year observational survey study on recurrence of hyperprolactinemia after pregnancy and lactation","volume":"98","author":"Auriemma","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12020-014-0334-7","article-title":"Prolactinomas, cabergoline, and pregnancy","volume":"47","author":"Glezer","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2016.04.001_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.1.02075","article-title":"Quinagolide\u00a0\u2013\u00a0a valuable treatment option for hyperprolactinaemia","volume":"154","author":"Barlier","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.04.001_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/jcem-48-1-9","article-title":"A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal and amniotic compartments","volume":"48","author":"Bigazzi","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0130","first-page":"758","article-title":"Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma","volume":"37","author":"Narita","year":"1985","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"key":"10.1016\/j.ando.2016.04.001_bib0135","first-page":"425","article-title":"Prolactin-producing microadenomas in pregnancy","volume":"62","author":"Divers","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2016.04.001_bib0140","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.25011\/cim.v35i2.16293","article-title":"Management of prolactinomas during pregnancy\u2013a survey of four Canadian provinces","volume":"35","author":"Almalki","year":"2012","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.ando.2016.04.001_bib0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pbiomolbio.2004.08.010","article-title":"A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus","volume":"87","author":"De Wilde","year":"2005","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.ando.2016.04.001_bib0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.amjsurg.2005.03.033","article-title":"Pregnancy outcome following non-obstetric surgical intervention","volume":"190","author":"Cohen-Kerem","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.ando.2016.04.001_bib0155","first-page":"483","article-title":"Transsphenoidal surgery for a life-threatening prolactinoma apoplexy during pregnancy","volume":"33","author":"Witek","year":"2012","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.ando.2016.04.001_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4158\/EP12106.CR","article-title":"Apoplexy of a microprolactinoma during pregnancy: case report and review of literature","volume":"18","author":"Couture","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2016.04.001_bib0165","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0015-0282(16)59182-1","article-title":"Relationship between the methods of treatment for prolactinomas and the puerperal lactation","volume":"47","author":"Ikegami","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2016.04.001_bib0170","first-page":"407","article-title":"The effect of pregnancy and lactation on pituitary prolactin-secreting tumours","volume":"92","author":"Zarate","year":"1979","journal-title":"Acta Endocrinol (Copenhague)"},{"key":"10.1016\/j.ando.2016.04.001_bib0175","first-page":"452","article-title":"Women with prolactinoma\u2013effect of pregnancy and lactation on serum prolactin and on tumour growth","volume":"111","author":"Holmgren","year":"1986","journal-title":"Acta Endocrinol (Copenhague)"},{"key":"10.1016\/j.ando.2016.04.001_bib0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-2243(92)90094-F","article-title":"Long term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women","volume":"44","author":"Crosignani","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ando.2016.04.001_bib0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2265.1996.00824.x","article-title":"Long term follow-up of patients with hyperprolactinaemia","volume":"45","author":"Jeffcoate","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2016.04.001_bib0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2265.2009.03657.x","article-title":"Factors determining the remission of microprolactinomas after dopamine agonist withdrawal","volume":"72","author":"Huda","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2016.04.001_bib0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2009-1238","article-title":"Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis","volume":"95","author":"Dekkers","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.04.001_bib0200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","article-title":"Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis","volume":"18","author":"Hu","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2016.04.001_bib0205","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1210\/jc.2008-2103","article-title":"Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy","volume":"94","author":"Kharlip","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616300166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616300166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:20Z","timestamp":1757717300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426616300166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0003426616300166"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2016.04.001","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactinoma and pregnancy: From the wish of conception to lactation","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}